The stock hit 2 new 52 week lows recently. One on the 7th of February, 2022, and another low on the 10th of February, 2022.
Two back to back 52 week lows is VERY BEARISH! Also, looks like shorts are back at it.
One thing that many of you who are pumping on the Low float of
$SBFM
forget is that this thing can plummet very easily because of the low float just as much as it can go up.
They have not progressed beyond rat trials in 10+ years with adva-27a, despite numerous attempts to pump, that drug has gone nowhere.
There is no evidence that either Adva-27a or SBFMPL4 work in humans. Many drugs have shown promising data when at the same stage as SBFM, but then the trials progress and things go down hill, Merck’s antiviral is a good example. Anyone who assumes consistent results in these trials is clueless.
And Pfizer already dominates the market in terms of vaccines and anti-virals. Plus, no one cares about covid anymore, and the politicians that care about Covid are gonna get tanked in midterms like the SBFM share price tanked yesterday.
The hype around covid stocks from 2020 & 2021 just won’t be there. And SBFM won’t even have a marketable product for another 1-2 years under their best case scenario, per their own SEC filings.
Nearly 89% of value lost in 8 months…
Nearly half of all value lost in less than 2 days post-split.
With dilution incoming, more value will be lost.
All the people saying this was a good investment forget the plain math that tells us it was a bad investment.
Lmao. Do the Math. Nearly all value was lost, the earnings per share is EXTREMELY NEGATIVE.
